Company intelligence / Profile preview

Intrinsic Therapeutics

Woburn, Massachusetts, United Statesbarricaid.com ↗

Ownership: Private
Development stage: Commercial

Overview

Barricaid®, the company’s proprietary bone-anchored annular closure device, is commercially available and has been implanted in over 12,000 patients. Multiple clinical studies—including two randomized controlled trials and six single-arm trials—demonstrate that Barricaid reduces reherniation and reoperation rates by up to 81% compared to discectomy alone. Five-year follow-up data published in JAMA confirm its superiority over standard care for high-risk patients with large annular defects.

Therapeutic areas: Neurology
Modalities: DeviceImplantable medical deviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Barricaid

Commercial

Indications: Lumbar disc herniation, Recurrent disc herniation

Partnerships

Questa Capital (investor/partner)NEA/New Enterprise Associates (investor/board representation)No major pharma or biotech commercial partnerships disclosed.

Beyond the preview

Go deeper on Intrinsic Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intrinsic Therapeutics.

Explore the full profile